Microviable Therapeutics is awarded with the Seal of Excellence by the European Commission under the EU Framework Programme H2020 for Research and Innovation.
Microviable obtained the high-quality score (excellence, impact, quality and efficiency of implementation) and the Seal of Excellence certificate of the European Commission, as the institution managing Horizon 2020 Research&Innovation program, for the project “Anaerobic long-term preservation of gut microbiota to unleash new therapeutic benefits”.
This award is a recognition to the quality, excellence, impact and efficiency of the proposed project “Anaerobic long-term preservation of gut microbiota to unleash new therapeutic benefits”